CryoLife (Germany) Top Insiders

CryoLife Management Team Effectiveness

The company has return on total asset (ROA) of 0.0122 % which means that it generated a profit of $0.0122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0656) %, meaning that it generated substantial loss on money invested by shareholders. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities. CryoLife holds a total of 40.56 Million outstanding shares. The majority of CryoLife outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CryoLife to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in CryoLife. Please pay attention to any change in the institutional holdings of CryoLife as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as CryoLife in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of CryoLife, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

CryoLife Workforce Comparison

The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.

CryoLife Benchmark Summation

CryoLife Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as CryoLife often depends on how effective the management is. CryoLife management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CryoLife management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CryoLife management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running CryoLife's price analysis, check to measure CryoLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoLife is operating at the current time. Most of CryoLife's value examination focuses on studying past and present price action to predict the probability of CryoLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoLife's price. Additionally, you may evaluate how the addition of CryoLife to your portfolios can decrease your overall portfolio volatility.